bibliographicCitation |
Kwan TK, Ma ES, Chan YY, Wan TS, Liu HS, Sim JP, Yeung YM, Lie AK, Yip SF. BCR-ABL mutational studies for predicting the response of patients with chronic myeloid leukaemia to second-generation tyrosine kinase inhibitors after imatinib failure. Hong Kong Med J. 2009 Oct;15(5):365–73. PMID: 19801694. |